MedPath

Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis

Not Applicable
Completed
Conditions
Arsenical Keratosis
Interventions
Other: Leaf extract of A. indica
Drug: Salicylic Acid (6%)
Other: Petroleum jelly
Registration Number
NCT01731756
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Brief Summary

Effects of leaf extract of Azadirachta indica in palmer arsenical keratosis: Randomized, double-blind, placebo-control trial

Detailed Description

The objective of this study is to evaluate the effectiveness of topical administration of the Leaf of Azadirachta indica in the treatment of palmer arsenical keratosis. Fifty patients of moderate palmer arsenical keratosis patients from an arsenic affected area will be recruited on the basis of inclusion and exclusion criteria and had been drinking arsenic contaminated water for more than six months. They will be divided into two groups each will consist of twenty five members. One group will be provided A. indica plus 6% salicylic acid ointment to apply on palm overnight daily for 12 weeks. Another group will be provided 6% salicylic acid ointment . Water and nail sample will be collected before starting recruitment to confirm diagnosis. Then again nail sample will be collected before and after the study to see the level of arsenic in skin. Effects will be observed after every two weeks and change will be detected as nil, mild reduction, moderate reduction and fully cured.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Palmer arsenical keratosis
  • Drinking arsenic contaminated water (>50 ppb) for more than six months
  • Patient voluntarily agree to participate
Exclusion Criteria
  • Pregnancy
  • Lactating mother
  • Diabetes mellitus
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Psoriasis
  • Bowen's disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Palmer arsenical keratosis (study)Leaf extract of A. indicaLeaf extract of A. indica plus salicylic acid (6%) in petroleum jelly base will be applied on palmer keratotic lesion once daily at bedtime for 12 weeks
Palmer arsenical keratosis (study)Salicylic Acid (6%)Leaf extract of A. indica plus salicylic acid (6%) in petroleum jelly base will be applied on palmer keratotic lesion once daily at bedtime for 12 weeks
Palmer arsenical keratosis (study)Petroleum jellyLeaf extract of A. indica plus salicylic acid (6%) in petroleum jelly base will be applied on palmer keratotic lesion once daily at bedtime for 12 weeks
Palmer arsenical keratosis (control)Salicylic Acid (6%)Salicylic acid (6%) in petroleum jelly base will be applied on palmer keratotic lesion once daily at bedtime for 12 weeks
Palmer arsenical keratosis (control)Petroleum jellySalicylic acid (6%) in petroleum jelly base will be applied on palmer keratotic lesion once daily at bedtime for 12 weeks
Primary Outcome Measures
NameTimeMethod
Changes in palmer arsenical keratosis0 week (baseline), 12 weeks (end)

Size and number of keratotic lesions will be reduced. These will be expressed in score.

Secondary Outcome Measures
NameTimeMethod
Changes in arsenic level in nail0 week (baseline), 12 weeks (end)

Arsenic level in nail of the patient will be decrease. Total arsenic level will be estimated by atomic fluorescence spectrometer.

Trial Locations

Locations (1)

Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University

🇧🇩

Dhaka, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath